Inactive Instrument
Cell MedX Corp Stock OTC Bulletin Board
Stocks
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
OTC Bulletin Board
|
||
| - USD | - |
|
| Market Cap | 4.65M 4.08M 3.85M 3.51M 6.58M 446M 6.62M 46.13M 17.87M 228M 17.46M 17.09M 732M | P/E 2027 * |
-11x | P/E 2028 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 4.65M 4.08M 3.85M 3.51M 6.58M 446M 6.62M 46.13M 17.87M 228M 17.46M 17.09M 732M | EV / Sales 2027 * |
-
| EV / Sales 2028 * | 7.75x |
| Free-Float |
28.33% | Yield 2027 * |
-
| Yield 2028 * | - |
| Manager | Title | Age | Since |
|---|---|---|---|
David Jeffs
CEO | Chief Executive Officer | 56 | 12/12/2023 |
Yanika Silina
DFI | Director of Finance/CFO | 48 | 24/11/2014 |
| Director | Title | Age | Since |
|---|---|---|---|
George Adams
CHM | Chairman | 74 | 26/02/2024 |
Joao da Costa
BRD | Director/Board Member | 62 | 08/06/2020 |
David Jeffs
BRD | Director/Board Member | 56 | 12/12/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.14% | +4.33% | +9.88% | +31.73% | 48.01B | ||
| -1.69% | +1.48% | +53.02% | +33.59% | 45.27B | ||
| +2.56% | +7.34% | +382.17% | +594.81% | 42.84B | ||
| +0.24% | +2.85% | +9.78% | +89.54% | 40.93B | ||
| -0.62% | -1.11% | +4.70% | +46.02% | 29.6B | ||
| -0.28% | +1.07% | +26.83% | +152.91% | 17.32B | ||
| -0.46% | +1.20% | +26.78% | +41.32% | 15.34B | ||
| -2.21% | -4.70% | - | - | 15.15B | ||
| +3.37% | +9.21% | +9.93% | - | 14.84B | ||
| Average | +0.09% | +1.60% | +65.39% | +141.42% | 29.92B | |
| Weighted average by Cap. | +0.08% | +1.77% | +81.87% | +153.92% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | - | 600K 526K 497K 453K 848K 57.51M 854K 5.95M 2.3M 29.38M 2.25M 2.2M 94.42M |
| Net income | -510K -448K -423K -385K -721K -48.88M -726K -5.06M -1.96M -24.97M -1.91M -1.87M -80.26M | - |
| Net Debt | - | - |
Employees
-
Select your edition
All financial news and data tailored to specific country editions
















